Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by ALLERGAN
FDA Drug Application 021184 by ALLERGAN
Application Number
021184
Application Type
New Drug Application
Sponsor Applicant
ALLERGAN
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New formulation
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
9/29/2000
N
1405
000
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21184ltr.pdf
9/29/2000
AP
0
9/29/2000
N
1406
000
http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21184lbl.pdf
9/29/2000
AP
0
9/29/2000
N
8094
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-184_Tazorac.cfm
3/28/2004
AP
0
10/11/2001
SE1
3381
001
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/21184s1ltr.pdf
10/24/2001
AP
0
10/11/2001
SE1
3382
001
http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21184s1lbl.pdf
10/24/2001
AP
0
10/11/2001
SE1
3384
001
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-184S001_Tazorac.cfm
12/12/2001
AP
0
9/30/2002
SE1
7568
002
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-184s002_Avage.cfm
1/15/2004
AP
0
9/30/2002
SE1
8771
002
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21184se1-002ltr.pdf
5/27/2004
AP
0
9/30/2002
SE1
8772
002
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21184s2lbl.pdf
5/27/2004
AP
0
12/13/2013
SLR
38063
007
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021184Orig1s007ltr.pdf
12/17/2013
AP
0
12/13/2013
SLR
38091
007
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021184s007lbl.pdf
12/17/2013
AP
0
9/16/2016
SLR
47117
008
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021184s008lbl.pdf
9/20/2016
AP
0
9/16/2016
SLR
47128
008
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021184Orig1s008ltr.pdf
9/21/2016
Back to FDA Applications sponsored by ALLERGAN